Navigation Links
Glycos Biotechnologies Appoints Chief Executive Officer

Growing Biochemical Company Adds Industry Veteran Rich Cilento to Leadership Team

(PRWEB) January 27, 2010 -- Glycos Biotechnologies, Inc. (GlycosBio), an emerging biochemical company pioneering metabolic engineering and microbiology innovations that produce green chemicals, today announced the appointment of Rich Cilento as Chief Executive Officer (CEO). A Venture Advisor for DFJ Mercury and currently Executive Chairman for GlycosBio, Cilento will now be responsible for the daily operations of the company as CEO.

“As Executive Chairman, Rich has made a tremendous impact on GlycosBio’s business in a very short amount of time helping to create the foundation for the company’s future growth,” said Dan Watkins, Managing Director of DFJ Mercury. “Rich has the business, technical and leadership experience necessary to drive and execute a successful go-to-market strategy while also remaining focused on the day-to-day operations of the company. This is an exciting time for GlycosBio and I’m confident with Rich’s guidance the company will achieve their business goals.”

With more than 20 years of leadership and technical experience in the petroleum, alternative energy, information technology and now biotechnology industries, Cilento has a proven track record of creating and managing successful businesses. Prior to his role as Executive Chairman for GlycosBio, Cilento held a variety of leadership positions throughout his career including his most recent position as Founder, President and CEO of FuelQuest, Inc. (acquired by Saracen Energy), a provider of on-demand supply chain management and tax automation software for suppliers, distributors, fuel buyers and traders in the global downstream energy marketplace. Cilento has also received national business honors winning the Ernst and Young Entrepreneur of the Year Award in 2006 for Energy Technology.

“GlycosBio has developed a truly unique technology to revolutionize the way the industry produces chemicals,” said Cilento. “These new biochemicals are 100% replacement products for the chemicals that are traditionally produced using fossil fuels and other unsustainable energy sources. Furthermore, to help meet the world’s growing demand for sustainable biochemicals and biofuels, GlycosBio’s techniques and processes create biochemicals that are an economic alternative to traditional chemical and fuel processes. With some of the industry’s brightest scientists and most experienced researchers on its team, GlycosBio has already attracted the attention of prominent biofuel and chemical companies worldwide and is on the verge of announcing many exciting commercialization efforts and scientific discoveries. I look forward to leading GlycosBio and our talented and dedicated team towards a vision of producing environmentally clean biochemicals that can compete head to head with traditional fossil fuels based petrochemicals.”

About Glycos Biotechnologies, Inc.
Glycos Biotechnologies, Inc. (GlycosBio) is an emerging biochemical company pioneering the metabolic engineering of microbial strains to consume multiple non sugar-based, low value feedstocks for the production of sustainable chemical intermediates and advanced ethanol. By designing differentiated microorganisms, GlycosBio’s bioconversion technology lowers production cost and provides a non food energy balance savings to the chemical and biofuel industries. GlycosBio is privately held with established global relationships focused on product commercialization. For more information, visit


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Glycos Biotechnologies, Inc. Selected to Present at Alternative Energy Innovations 2009
2. Microchip Biotechnologies Raises $18.1M in Series B Financing
3. Epeius Biotechnologies to Partner at BIO Investor Forum
4. Variation Biotechnologies Names Jeff Baxter CEO
5. TriLink BioTechnologies, Inc. Relaunches Oligonucleotide Radiolabeling Services
6. TriLink BioTechnologies to Sponsor GIVING HUNGER THE BLUES, a Benefit Concert to Help Alleviate Hunger in San Diego County
7. Andre Marion Joins Microchip Biotechnologies Board of Directors
8. Solos Endoscopy, Inc. Sells Ovascope and Mastascope Product Line to Lifeline Biotechnologies, Inc.
9. Commonwealth Biotechnologies Presents Data at Forensic Sciences Meeting Confirming Benefits of ZyGEMs DNA Extraction Technology
10. Beginners Luck, or Creative Artists of the First Rank? Epeius Biotechnologies Launches Rexin-G eBook Tutorial
11. Richter-Helm and Athera Biotechnologies Partner in Development of Recombinant Protein to Treat Cardiovascular Disease
Post Your Comments:
Related Image:
Glycos Biotechnologies Appoints Chief Executive Officer 
(Date:11/27/2015)... 2015 --> ... companion diagnostics is one of the major ... pharmaceutical companies and diagnostic manufacturers working together ... . --> ... global cancer biomarkers market spread across 89 ...
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
(Date:11/25/2015)...  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced ... of Neurocrine Biosciences, will be presenting at the 27th ... York . .   ... minutes prior to the presentation to download or install ... be available on the website approximately one hour after ...
(Date:11/25/2015)... PORTLAND, Oregon , November 25, 2015 /PRNewswire/ ... Deep Market Research Report is a professional and ... Genomics industry.      (Logo: ... basic overview of the industry including definitions, classifications, ... analysis is provided for the international markets including ...
Breaking Biology Technology:
(Date:11/9/2015)... DUBLIN , Nov. 09, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Law Enforcement Biometrics Market 2015-2019" ... Research and Markets ( ) ...
(Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
(Date:10/29/2015)... 29, 2015   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that it ... (MHTA) as one of only three finalists for a ... Small and Growing" category. The Tekne Awards honor ... superior technology innovation and leadership. iMedNet™ ...
Breaking Biology News(10 mins):